Windlas Biotech IPO Reviews, Dates, Price Band, Market Lot & Financial Details 2021

The Windlas Biotech IPO will hit the market soon, and you can apply for the IPO from 4th August to 6th August 2021. Windlas Biotech is planning to raise ₹401.54 Crores through an IPO which consists of a fresh issue of ₹165 crores worth equity and OFS (Offer For Sale) of ₹236.54 by existing shareholders.

The company was incorporated in 2001 in Dehradun. The company is famous in the field of contract development and manufacturing organizations (CDMO) in India. They also offer special pharmaceutical development and manufacturing services to their clients. With more than 900 employees at the Dehradun unit, they are delivering efficient services to the clients. Also, check IPO GMP for upcoming IPOs.

Windlas Biotech IPO Dates & Price Band:

Open date4th August 2021
Close date6th August 2021
Total Size of IPO₹401.54 Cr.
Fresh Issue 165 Cr.
Offer for Sale₹236.54 Cr.
Price Band₹448 ₹460
Face Value₹5 per share
Listing onNSE and BSE
Retail Investor’s Portion35%

Windlas Biotech IPO Market Lot:

The minimum market lot of Windlas Biotech IPO is 30 shares with 13,800 applications. Retail investors can apply for 13 lots with 420 shares application worth193,200.

ApplicationLotSharesCut Off Amount
Minimum (RII)13013,800
Maximum (NII)13420193,200

Objective of Issue – 

  • To purchase equipment for production expansion.
  • To make repayment for borrowings secured by the company.
  • To meet general corporate purposes and working capital requirements.

Should you subscribe to Windlas Biotech IPO?

We have researched and mentioned the strengths and risks of the Windlas Biotech IPO. The final verdict will help you make the right decision.

Strengths –

  • Leading company in the field of formulation CDMO and domestic pharmaceutical formulation.
  • The R & D team is focused on chronic therapeutic categories and complex generic products.
  • Senior team of well experienced promoters.
  • Profitable financial track record.

Risks – 

  • Business profits are mostly reliant on CDMO client relationships. Any failure can impact their business.
  • The company operates from only one location (Dehradun). If they face any issues while operating through this location it can slow down their production.  
  • Uncertainty in the cost of raw materials can affect the net profits of the company.

Honest Review – 

We like Windlas Biotech for its business model and potential. The only thing that is concerning here is that profit after tax has decreased continuously over the last three years. 

Investors can invest for the listing gains in the Windlas Biotech IPO. It’s early to predict but Windlas Biotech IPO can give great listing gains by seeing its grey market premium. You can check details of Windlas Biotech IPO GMP here.

Windlas Biotech IPO Allotment & Listing Dates:

Windlas Biotech IPO’s open date is 4th August and the closing date is 6th August. Allotment of shares will be done on 11th August and the listing date on NSE & BSE is 17th August 2021.

Allotment Date for Windlas Biotech – 11th August 2021
Refund Date for Windlas Biotech – 12th August 2021
Credit of Shares to Demat Account – 13th August 2021
Listing Date for Windlas Biotech –17th August 2021

Applying IPO through the form: 

Besides applying IPOs through ASBA application or through Demat accounts you can also apply to IPOs with the help of forms provided by NSE or BSE. This is one of the traditional and safe ways to apply for an IPO subscription. Download the form through this link and fill the form carefully. You have to submit your filled form to the bank or broker.

Financials of Windlas Biotech IPO:

The financials of Windlas Biotech are very attractive. From 2019 the revenue numbers are increasing constantly. Net income is also increasing slightly. Upcoming financial numbers are expected to be good so we suggest investors apply for the IPO.

YearRevenue (₹ in Cr.)Expense (₹ in Cr.)PAT Net Income (₹ in Cr.)
201929831263.32
2020 33733116.12
2021 29643115.60

IPO Registrar Details –

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083
Phone: +91-22-4918 6270
Email: [email protected]
Website: http://www.linkintime.co.in

Windlas Biotech Contact Details –

Windlas Biotech Limited
40/1, Mohabewala Industrial Area,
Dehradun, 248110
Phone: +91 135 6608000
Email: [email protected]
Website: http://www.windlasbiotech.com/

Windlas Biotech IPO FAQs –


When will Windlas Biotech IPO open for Investors?

Windlas Biotech IPO will open on 4th August 2021 and will close on 6th August 2021.

What is Windlas Biotech IPO Retail Portion?

The portion allocated for retail investors in Windlas Biotech IPO is 35%

How to apply for Windlas Biotech IPO?

You can apply Windlas Biotechl IPO in 3 ways:
Open a Demat account through a bank or brokerage firm and apply through it.
Apply via ASBA application online through your bank.
Fill up the offline IPO form and submit it to the bank or broker.

Should I invest in Windlas Biotech IPO?

We like Windlas Biotech for its business model and potential. The only thing that is concerning here is that profit after tax has decreased continuously over the last three years. 

What is the allotment date for Windlas Biotech shares?

4th August 2021 is the allotment date for Windlas Biotech shares.

What is the listing date for Windlas Biotech IPO?

11th August 2021 is the listing date for Windlas Biotech. It will be listed on NSE and BSE.

What is the cutoff price for Windlas Biotech IPO?

The cutoff price for Windlas Biotech IPO is ₹460 per share.

Will Windlas Biotech IPO give listing gains?

Investors can invest for the long term in Windlas Biotech. It’s early to predict but Windlas Biotech can give great listing gains by seeing its grey market premium. You can keep a track of Windlas Biotech IPO GMP here. 


Disclaimer for Investors:

  • We on ipogmp.in do not buy or sell any kind of IPO forms.  
  • Do not subscribe to IPO just by seeing its GMP. You should do proper research about the fundamentals of a company.
  • IPO GMP changes every day and you can view the changes in the above table.
  • Always apply to an IPO after understanding financials and discussing with your financial advisor.
Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *